Angiotech Pharmaceuticals
Vancouver · Founded 1989
About Angiotech Pharmaceuticals
Angiotech is a Vancouver, British Columbia pharmaceutical company. Its products enhance the performance of medical devices and biomaterials through the use of pharmacotherapeutics. Angiotech is a global specialty pharmaceutical and medical device company that discovers, develops, and markets innovative technologies and medical products primarily for local diseases or for complications associated with medical device implants, surgical interventions and acute injury.
Company Facts
- Founded: 1989
- Legal name: Surgical Specialties Corporation
- Operating status: Acquired
- Company type: For Profit
- IPO status: Private
- Employees: 1,001 – 5,000
- Estimated revenue: $100K – $500K
- Funding stage: M&A
- Last round: Series Unknown (Mar 2017)
- Website: surgicalspecialties.com
- Phone: 877.991.1110
Social Profiles
Canonical: https://fsome.com/organization/angiotech-pharmaceuticals-8304668 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.